Literature DB >> 16735448

Regulation of glucose transporters by insulin and extracellular glucose in C2C12 myotubes.

Taku Nedachi1, Makoto Kanzaki.   

Abstract

It is well established that insulin stimulation of glucose uptake in skeletal muscle cells is mediated through translocation of GLUT4 from intracellular storage sites to the cell surface. However, the established skeletal muscle cell lines, with the exception of L6 myocytes, reportedly show minimal insulin-dependent glucose uptake and GLUT4 translocation. Using C(2)C(12) myocytes expressing exofacial-Myc-GLUT4-enhanced cyan fluorescent protein, we herein show that differentiated C(2)C(12) myotubes are equipped with basic GLUT4 translocation machinery that can be activated by insulin stimulation ( approximately 3-fold increase as assessed by anti-Myc antibody uptake and immunostaining assay). However, this insulin stimulation of GLUT4 translocation was difficult to demonstrate with a conventional 2-deoxyglucose uptake assay because of markedly elevated basal glucose uptake via other glucose transporter(s). Intriguingly, the basal glucose transport activity in C(2)C(12) myotubes appeared to be acutely suppressed within 5 min by preincubation with a pathophysiologically high level of extracellular glucose (25 mM). In contrast, this activity was augmented by acute glucose deprivation via an unidentified mechanism that is independent of GLUT4 translocation but is dependent on phosphatidylinositol 3-kinase activity. Taken together, these findings indicate that regulation of the facilitative glucose transport system in differentiated C(2)C(12) myotubes can be achieved through surprisingly acute glucose-dependent modulation of the activity of glucose transporter(s), which apparently contributes to obscuring the insulin augmentation of glucose uptake elicited by GLUT4 translocation. We herein also describe several methods of monitoring insulin-dependent glucose uptake in C(2)C(12) myotubes and propose this cell line to be a useful model for analyzing GLUT4 translocation in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735448     DOI: 10.1152/ajpendo.00194.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  36 in total

1.  Contractile activity of human skeletal muscle cells prevents insulin resistance by inhibiting pro-inflammatory signalling pathways.

Authors:  S Lambernd; A Taube; A Schober; B Platzbecker; S W Görgens; R Schlich; K Jeruschke; J Weiss; K Eckardt; J Eckel
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

Review 2.  Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications.

Authors:  Serge Ostrovidov; Vahid Hosseini; Samad Ahadian; Toshinori Fujie; Selvakumar Prakash Parthiban; Murugan Ramalingam; Hojae Bae; Hirokazu Kaji; Ali Khademhosseini
Journal:  Tissue Eng Part B Rev       Date:  2014-02-24       Impact factor: 6.389

3.  Quantifying intracellular rates of glycolytic and oxidative ATP production and consumption using extracellular flux measurements.

Authors:  Shona A Mookerjee; Akos A Gerencser; David G Nicholls; Martin D Brand
Journal:  J Biol Chem       Date:  2017-03-07       Impact factor: 5.157

4.  Nox2 mediates skeletal muscle insulin resistance induced by a high fat diet.

Authors:  Alvaro Souto Padron de Figueiredo; Adam B Salmon; Francesca Bruno; Fabio Jimenez; Herman G Martinez; Ganesh V Halade; Seema S Ahuja; Robert A Clark; Ralph A DeFronzo; Hanna E Abboud; Amina El Jamali
Journal:  J Biol Chem       Date:  2015-03-30       Impact factor: 5.157

5.  Identification of three distinct functional sites of insulin-mediated GLUT4 trafficking in adipocytes using quantitative single molecule imaging.

Authors:  Hideaki Fujita; Hiroyasu Hatakeyama; Tomonobu M Watanabe; Masaaki Sato; Hideo Higuchi; Makoto Kanzaki
Journal:  Mol Biol Cell       Date:  2010-06-02       Impact factor: 4.138

6.  Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.

Authors:  Evgeniy Panzhinskiy; Yinan Hua; Paul A Lapchak; Elena Topchiy; Teresa E Lehmann; Jun Ren; Sreejayan Nair
Journal:  J Pharmacol Exp Ther       Date:  2014-02-18       Impact factor: 4.030

7.  2-(3,4-Dihydro-2H-pyrrolium-1-yl)-3oxoindan-1-olate (DHPO), a novel, synthetic small molecule that alleviates insulin resistance and lipid abnormalities.

Authors:  Machender R Kandadi; Prabhakar K Rajanna; Mazhuvancherry K Unnikrishnan; Sai P Boddu; Yinan Hua; Ji Li; Min Du; Jun Ren; Nair Sreejayan
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

8.  Ceramide 1-phosphate stimulates glucose uptake in macrophages.

Authors:  Alberto Ouro; Lide Arana; Patricia Gangoiti; Io-Guané Rivera; Marta Ordoñez; Miguel Trueba; Ravi S Lankalapalli; Robert Bittman; Antonio Gomez-Muñoz
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

9.  Insulin-Based Regulation of Glucose-functionalized Nanoparticle Uptake in Muscle Cells.

Authors:  Yi-Cheun Yeh; Sung Tae Kim; Rui Tang; Bo Yan; Vincent M Rotello
Journal:  J Mater Chem B       Date:  2014-05       Impact factor: 6.331

10.  Prostaglandin A2 enhances cellular insulin sensitivity via a mechanism that involves the orphan nuclear receptor NR4A3.

Authors:  X Zhu; R G Walton; L Tian; N Luo; S-R Ho; Y Fu; W T Garvey
Journal:  Horm Metab Res       Date:  2012-10-26       Impact factor: 2.936

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.